Similar articles

• Immunotherapy in the treatment of acute leukaemia.

  Whittaker JA. Whittaker JA. Br J Haematol. 1980 Jun;45(2):187-93. doi: 10.1111/j.1365-2141.1980.tb07137.x. Br J Haematol. 1980. PMID: 6934004 No abstract available.
• Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia.

  Char DH, Lepourhiet BG, Herberman RB. Char DH, et al. Int J Cancer. 1973 Sep 15;12(2):409-19. doi: 10.1002/ijc.2910120212. Int J Cancer. 1973. PMID: 4524930 No abstract available.
• The place of immunological methods of treatment in the management of acute leukaemia.

  Powles RL, Russell JA. Powles RL, et al. Hamatol Bluttransfus. 1976;19:297-304. doi: 10.1007/978-3-642-87524-3_31. Hamatol Bluttransfus. 1976. PMID: 795744 No abstract available.
• Immunotherapy of leukemia and lymphoma.

  Murphy S, Hersh E. Murphy S, et al. Semin Hematol. 1978 Apr;15(2):181-203. Semin Hematol. 1978. PMID: 418506 Review. No abstract available.
• Immunotherapy of cancer in man: current status and prospectus.

  Carter SK. Carter SK. Ann N Y Acad Sci. 1976;277(00):722-40. doi: 10.1111/j.1749-6632.1976.tb41745.x. Ann N Y Acad Sci. 1976. PMID: 793477 Review. No abstract available.